388 related articles for article (PubMed ID: 10075865)
21. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
Mosesson MW
Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789
[TBL] [Abstract][Full Text] [Related]
22. Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation.
Chen A; Gaddipati S; Hong Y; Volkman DJ; Peerschke EI; Ghebrehiwet B
J Immunol; 1994 Aug; 153(4):1430-40. PubMed ID: 8046223
[TBL] [Abstract][Full Text] [Related]
23. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
Sangrar W; Koschinsky ML
Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
[TBL] [Abstract][Full Text] [Related]
25. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
26. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
J Immunol; 1993 Oct; 151(8):4315-24. PubMed ID: 8409404
[TBL] [Abstract][Full Text] [Related]
27. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
28. Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications.
Galanakis DK
Semin Thromb Hemost; 1992 Jan; 18(1):44-52. PubMed ID: 1574716
[TBL] [Abstract][Full Text] [Related]
29. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.
Zlatarova AS; Rouseva M; Roumenina LT; Gadjeva M; Kolev M; Dobrev I; Olova N; Ghai R; Jensenius JC; Reid KB; Kishore U; Kojouharova MS
Biochemistry; 2006 Aug; 45(33):9979-88. PubMed ID: 16906756
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
31. Multiple interactions of FbsA, a surface protein from Streptococcus agalactiae, with fibrinogen: affinity, stoichiometry, and structural characterization.
Pietrocola G; Visai L; Valtulina V; Vignati E; Rindi S; Arciola CR; Piazza R; Speziale P
Biochemistry; 2006 Oct; 45(42):12840-52. PubMed ID: 17042502
[TBL] [Abstract][Full Text] [Related]
32. Platelet C1q receptor interactions with collagen- and C1q-coated surfaces.
Peerschke EI; Ghebrehiwet B
J Immunol; 1990 Nov; 145(9):2984-8. PubMed ID: 2212670
[TBL] [Abstract][Full Text] [Related]
33. gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection.
Ghebrehiwet B; Lim BL; Kumar R; Feng X; Peerschke EI
Immunol Rev; 2001 Apr; 180():65-77. PubMed ID: 11414365
[TBL] [Abstract][Full Text] [Related]
34. C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors.
Khalkhali-Ellis Z; Bulla GA; Schlesinger LS; Kirschmann DA; Moore TL; Hendrix MJ
J Immunol; 1999 Oct; 163(8):4612-20. PubMed ID: 10510406
[TBL] [Abstract][Full Text] [Related]
35. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii.
Malinconico SM; Katz JB; Budzynski AZ
J Lab Clin Med; 1984 Nov; 104(5):842-54. PubMed ID: 6387015
[TBL] [Abstract][Full Text] [Related]
36. A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.
Galanakis DK; Ghebrehiwet B
J Clin Invest; 1994 Jan; 93(1):303-10. PubMed ID: 8282801
[TBL] [Abstract][Full Text] [Related]
37. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
38. C1q interactions with cell surface receptors.
Tenner AJ
Behring Inst Mitt; 1989 Jul; (84):220-9. PubMed ID: 2679535
[TBL] [Abstract][Full Text] [Related]
39. Modification of fibrin network ultrastructure by Fab fragments specific for different domain of fibrinogen.
Cierniewski CS; Janiak A; Wyroba E
Acta Biochim Pol; 1986; 33(3):195-202. PubMed ID: 2433859
[TBL] [Abstract][Full Text] [Related]
40. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
Krajewski T; Nowak P; Cierniewski C
Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
